Gene Query: RTCB

Dataset Description Geneva Score
Transcriptome analysis of immature and matured human oocytes from patients of young and advanced maternal age 48.3
Effects of rFVIIIFc on human macrophages 30.26
Stimulation of isolated plasmacytoid dendritic cells (pDCs) with TLR9 agonist CpG C (CpG) and TLR7 agonist imiquimod (IMQ) 27.35
RNA-seq analysis of control and NRDE2-depleted breast cancer cells 20.41
Macrophage Ad5f35 M2 Challenge 20.03
Human CD4+CD103+ cutaneous resident memory T cells are found in the circulation of healthy subjects 19.92
The RNA hairpin binder TRIM71 modulates alternative splicing by repressing MBNL1 19.48
The RNA hairpin binder TRIM71 modulates alternative splicing by repressing Mbnl1 [RNA-seq & Ribo-seq] 19.48
Transcriptional change of THP-1 after HSV-1UL37WT or HSV-1UL37C819S 16.78
Presence of NAD+-capped RNA in human cells: function and removal by the DXO deNADing Protein 16.62
Identification of an NKX3.1-G9a-UTY regulatory network that controls prostate differentiation 16.31
Identification of an NKX3.1-G9a-UTY regulatory network that controls prostate differentiation (Human_RWPE1_RNA-Seq) 16.31
SRSF1 role in cellular gene expression and splicing 15.31
NRDE2 negatively regulates nuclear exosome functions 14.93
A transcriptome-wide divergence in protein translation scales with LIN28B expression 14.88
Epigenetic siRNA and chemical screens identify SETD8 inhibition as a new therapeutic strategy of p53 reactivation in high-risk Neuroblastoma. 14.56
Widespread N6-methyladenosine-dependent RNA Structural Switches Regulate RNA-Protein Interactions 14.56
Development of a selective CDK9 degrader from a multi-targeted CDK inhibitor 14.43
Development of a selective CDK9 degrader from a multi-targeted CDK inhibitor [RNA-seq] 14.43
Montelukast counteracts the influenza virus-induced block in unfolded protein stress response and reduces virus multiplication 14.41
NSD2 overexpression links drives clustered chromatin and transcriptional changes in a subset of insulated domains of insulated domains 14.16
Stem and effector CD8 T-cells from human cancers 14.06
Improved genome-wide mapping of uncapped and cleaved transcripts in eukaryotes—GMUCT 2.0 14.05
RNAseq to determine gene expression changes following depletion of SETDB1 in THP-1 AML Cells 13.84
Immune-restricted epigenetic reader SP140 maintains macrophage identity and activation states critical to intestinal homeostasis 13.68
Immune-restricted epigenetic reader SP140 maintains macrophage identity and activation states critical to intestinal homeostasis [RNA-seq] 13.68
Systematic discovery of endogenous human ribonucleoprotein complexes 13.19
SHQ1 regulation of RNA splicing is required for T-lymphoblastic leukemia cell survival 13.02
RNAseq of ribosomal fractionation to assess the effect of CBFB on translation regulation 12.94
U1 snRNP telescripting regulates size-function stratified human genome 12.84
A novel CD4+ T cell population expanded in SLE blood provides B cell help through IL10 and succinate 12.76
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation [cPDS-RNA-seq] 12.68
Transcriptome wide analysis of translation efficiency in MCF7 cells using polysome profiling with and without eIF4A inhibition by hippuristanol treatment 12.4
Whole Transcriptome RNASeq Data for Cell-Sorted Antibody Secreting Cells (ASC) 12.39
Next Generation Sequencing upon siRNA-mediated knockdown of DRAIC in MCF-7 cells. 12.31
DHX15 regulates CMTR1-dependent gene expression and cell proliferation 12.24
12hr 5-FU treatment vs. DMSO in SJSA cells (from 'A kinase independent role for CDK19 in p53 response') 12.21
Enhancement of Arterial Specification in Human Pluripotent Stem Cell Cultures Promotes Definitive Hematoendothelial Program with Broad Myelolymphoid Potential 12.19
Identification of diverse target RNAs that are functionally regulated by human Pumilio proteins 12.13
miR-191 regulates human cell proliferation and directly targets multiple oncogenes [seq] 12.12
Genome wide miR-191 target profile determined by RIP and gene expression profiling 12.12
Mitochondrial dsRNA triggers antiviral signalling in humans 12.11
Biochemical fractionation of HEK293 nuclei and RNA-seq of chromatin-associated and soluble-nuclear RNA 11.68
RNA-seq of RKO cells with cTAZ KO or putback 11.68
The ZZ-type zinc finger of ZZZ3 modulates the ATAC complex-mediated histone acetylation and gene activation 11.67
ChIP-seq and RNA-seq in BGC823 cells after downregulation of GAS1 expression 11.61
A novel lncRNA GAS1 promotes gastric carcinogenesis and acts as a modular scaffold of WDR5 and KAT2A complexes to specify the histone modification pattern [RNA-seq] 11.61
mRNA expression profile of Lymphocytes 11.54
RNA-seq transcriptonal profiling in human primary adult erythroid progenitor cells (ProEs) after shRNA-mediated depletion of TFAM and PHB2 expression 11.51
Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21 (RNA-Seq) 11.38
Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21 11.38
Quiescent glioblastoma cells shift to an epithelial-mesenchymal transition-like gene program 11.36
Comparative transcriptomic analysis of human and Drosophila extracellular vesicles reveals extensive conservation 11.07
Response of HEK293 Freestyle cells to 36 h of culture in Zn(II)-depleted Freestyle medium 11.02
Cellular gene expression during Hepatitis C Virus replication revealed by Ribosome profiling 10.88
Inducible three-factor direct reprogramming to nephron progenitors using piggyBac transposons 10.76
RNA-sequencing of shSRC-1 and shNT tamoxifen treated LY2 cells 10.71
RNA-sequencing and MeDIP-sequencing of shSRC-1 and shNT tamoxifen treated LY2 cells 10.71
Identification of elevated A-to-I editing sites due to expression of an active ADAR3 mutant in human glioblastoma cells 10.71
Effect of hyperfractionated irradiation (HFRT) of prostate primary basal cells (PrEPs) on the transcriptome 10.6
Isolation and Transcriptome Analyses of Human Erythroid Progenitors: BFU-E and CFU-E 10.58
Tracking distinct RNA populations using efficient and reversible covalent chemistry 10.44
Transcription elongation factors are in vivo-specific cancer dependencies in glioma 10.33
RNA-seq Profiles in Transcription elongation factors are in vivo-specific cancer dependencies in glioma 10.33
Identification of transcription start sites for human A549 cell line using ReCappable-seq 10.31
A Novel PI3K Regulator, ARID4B, Presents Synthetic Essentiality in PTEN-deficient Prostate Cancer [RNA-seq] 10.23
A Novel PI3K Regulator, ARID4B, Presents Synthetic Essentiality in PTEN-deficient Prostate Cancer 10.23
Human Adult Sorted Live Cell Erythroblasts transduced with Sigma shRNA Clone TRCN0000005418 targeting RIOK3 with puromycin selection RNAseq 10.21
The DPYSL2 gene connects mTOR and schizophrenia 10.15
RNAseq to determine whether bidirectional transcription occurs over transposable elements following depletion of SETDB1 in THP-1 AML Cells 10.13
Circular RNAs are down-regulated in KRAS mutant colon cancer cells and can be transferred to exosomes 10.05
Loss of CHD1 facilitates oncogenic hijacking of AR during cancer progression 9.95
Loss of CHD1 facilitates oncogenic hijacking of AR during cancer progression [RNA-seq] 9.95
SNHG12 knockdown in Human Umbilical Vein Cells under ROS conditions. 9.81
Genome-wide CRISPR-Cas9 screen identifies druggable synthetic lethality between LSD1 and MTORC1 in MLL-translocated AML 9.73
ELF4 is a target of miR-124 and promotes neuroblastoma proliferation and undifferentiated state 9.63
Proteinase-Activated Receptor 4 (PAR4) mediates cell membrane blebbing in a Gaq/11, Gai independent, RhoA and ß-arrestin-dependent manner. 9.61
3’ Uridylation Expands miRNA Target Repertoire 9.6
TT-Seq captures the human transient transcriptome 9.53
Transcriptome analysis of Jurkat T-ALL clones from control and CBAP-knockdown/knockout sets 9.5
Macrophage Ad5f35 PhenoMap 9.46
Base-resolution mapping reveals distinct classes of N1-methyladenosine methylome in nuclear- and mitochondrial-encoded transcripts 9.44
Antibiotics induce polarization of pleural macrophages to M2-like phenotype in patients with tuberculous pleuritis 9.35
Circular RNAs in the mammalian brain are highly abundant, conserved, and dynamically expressed 9.21
A SIRT1-centered Circuitry Regulates Breast Cancer Stemness and Metastasis 9.13
ADAR1 controls apoptosis of stressed cells by inhibiting Staufen-mediated mRNA decay 9.05
Comparison of single-cell transcriptomics quality between unfixed cells and cells that were fixed and mock stained according to the RAID procedure 8.99
Effect in HCT116 cells of 3hr cortistatin A treatment on gene expression. 8.92
Mediator kinase inhibition further activates super-enhancer-associated genes in AML 8.92
Integrative classification of human coding and non-coding genes based on RNA metabolism profiles 8.91
Expression data for KDM1B knockdown in Glioma-Initiating Cells (GICs) 8.89
Genome-wide RNA deep sequencing of CAL-101 or AKTi primed human T cells in comparison to traditionally expanded T cells 8.84
RNA sequencing (RNA-SEQ) of EPAS1 knockdown by siRNA in endothelial cells 8.74
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-Seq of LMNA KD) 8.73
RNA-seq analysis of activated plasmacytoid dendritic cell subsets after viral infection 8.68
The LIN28B/let-7 axis is a novel therapeutic pathway in Multiple Myeloma 8.55
Disrupted prenatal RNA processing and myogenesis in congenital myotonic dystrophy 8.55
Genomic and proteomic resolution of heterochromatin and its restriction of alternate fate genes 8.53
Genomic and proteomic resolution of heterochromatin and its restriction of alternate fate genes (RNA-seq) 8.53
The role of PHF19 in promoting H3K27me3 deposition in multiple myeloma (RNA-Seq) 8.53
The role of PHF19 in promoting H3K27me3 deposition in multiple myeloma 8.53
Reassessment of Exosome Composition 8.44
Tumors with TSC mutations are sensitive to CDK7 inhibition through NRF2 and glutathione depletion 8.4
Differential roles of human PUS10 in miRNA processing and tRNA pseudouridylation 8.38
Polysome profiling RNAseq of cells transfected with an oligonucleotide targeting the ES6S region of the 40S subunit 8.33
Transcriptome analysis upon C6orf203 silencing 8.27
A novel lncRNA lncRNA-AF339830 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc 8.27
A novel lncRNA lncRNA-AF339830 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc [RNA-Seq] 8.27
Dual role of CSL (RBP-Jk) and NOTCH1 in CAF 8.22
Dual role of CSL (RBP-Jk) and NOTCH1 in cancer-associated fibroblast genome stability and expansion [RNA-seq] 8.22
Comprehensive comparative analysis of 5’ end RNA sequencing methods 8.14
RNA-seq data for non-targeting siRNA and CDK11 siRNA transfection in SHhES8 cells 8.1
mRNA Sequencing of Human PromoCells Using Random Primed mRNA-Sequencing Technique 8.09
Sequencing Universal Human Reference RNA by Smart-seq and early barcoding library preparation methods 8.08
Extensive remodeling of DC function by rapid maturation-induced epigenetic gene silencing [RNA-Seq] 7.96
Extensive remodeling of DC function by rapid maturation-induced epigenetic gene silencing 7.96
ABCB5 is activated by MITF and b-catenin and is associated with melanoma differentiation 7.93
Agonistic targeting of TLR1/TLR2 induces p38 MAPK-dependent apoptosis and NfkB-dependent differentiation of AML cells 7.89
Developmental stage specific chromosome architecture in human erythroid cells (RNA-seq) 7.87
Developmental stage specific chromosome architecture in human erythroid cells 7.87
High-resolution liver cancer genomic profiling links etiology, epigenetic and mutation signatures [RNA-Seq] 7.7
High-resolution liver cancer genomic profiling links etiology, epigenetic and mutation signatures 7.7
A role for p53 in the adaptation to glutamine starvation through the expression of Slc1a3 7.65
Study functions of ADAR proteins using next generation sequencing of genome and transcriptome 7.64
The human blood-nerve barrier transcriptome 7.61
Aging of hematopoietic stem cells is driven by regional specialization of marrow macrophages 7.6
Human CD11b+ macrophages - Aging of hematopoietic stem cells is driven by regional specialization of marrow macrophages 7.6
Distinct gene expression profile of Huh7 cell lines stably overexpressing CRABP1 or 2 7.59
N6-methyladenosine mRNA marking promotes selective translation of regulons required for human erythropoiesis [RNA-Seq] 7.56
RNA-Seq of polysome profiling fractions and whole cell lysates of UVB-irradiated N-TERT keratinocytes 7.54
RNA-seq of resting and activated CD4+ T cells +-JQ1 7.53
RNA G-quadruplexes cause eIF4A-dependent oncogene translation in cancer 7.52
Differential expression of genes in AD169-infected MRC5. 7.51
Viral determinants in H5N1 influenza A virus enable productive infection of HeLa cells 7.46
mRNA and miRNA expression in primary human muscle cells treated with 1,25(OH)2D3 or vehicle 7.46
RNA expression in primary huamn muscle cells treated with 1,25(OH)2D3 or vehicle 7.46
Transcriptional Profiling Identifies Novel Regulators of Macrophage Polarization 7.43
Transcriptional Profiling Identifies Novel Regulators of Macrophage Polarization [RNA-Seq] 7.43
RUNX2/CBFB modulates the response to MEK inhibitors through activation of receptor tyrosine kinases in KRAS mutant colorectal cancer 7.42
Phosphatase inhibitor PPP1R11 modulates resistance of human T cells towards Treg-mediated suppression of TCR signaling 7.39
Role of XRN2 ribonucleolytic activity in RNA metabolism 7.37
Human Treg NaCl stimulation 7.36
Selective expansion of myeloid and NK cells in humanized mice yields human-like vaccine responses (Experiment 1: RNA-seq) 7.3
RNA sequencing of HepG2 cells treated with estradiol or estrogen receptor agonist 7.24
Gene Expression Profiling of SPOP Knocked Down Cell 7.23
TNF response in promyelocytic and granulocytic forms of HL60/S4 cells 7.21
AUF-1 affected genes in human skin cells 7.19
Genome wide expression change by RNF168 knocking down in NEC cells 7.13
Comparative Analysis of Cas9 Activators Across Multiple Species 7.1
NET-CAGE Characterizes the Dynamics and Topology of Human Transcribed Cis-regulatory Elements 7.04
Detection of internal N7-methylguanosine (m7G) RNA modifications by mutational profiling sequencing 7.03
SUV420H2 knockdown in PANC-1 6.98
Benzotriazoles reactivate latent HIV-1 through inactivation of STAT5 SUMOylation 6.94
Benzotriazoles reactivate latent HIV-1 through inactivation of STAT5 SUMOylation (RNA-Seq) 6.94
Tracing transcriptome profiles of human oocyte cultured by growth hormone or not in vitro by single cell RNA-seq 6.94
mRNA sequencing identifies differential gene expresssion profiles between ASCC3 knock-down cells and control cells 6.93
Dynamics of the human and viral m6A RNA methylomes during HIV-1 infection of T cells 6.91
MeRIP-seq for heat shock in B-cell lymphoma cells 6.91
Precise Gene Editing Preserves Hematopoietic Stem Cell Function Following Transient p53-Mediate DNA Damage Response [bulk RNA-seq] 6.88
Gene expression profiling of human MSC-educated macrophages vs. classical macrophages from bone marrow and blood 6.88
H3K27ac ChIP-Seq and mRNA-Seq analysis of five human B-lymphoblastoid cell lines (LCLs) prepared from the same healthy male individual (CEPH/UTAH). 6.84
CDK12 catalytic activity is rate-limiting for RNAPII processivity on core DNA replication genes and G1/S progression (3' RNA) 6.77
Analysis of the polyA+ RNA of LPS-treated human CD14+ monocytes 6.75
Next Generation Sequencing Facilitates Quantitative Analysis of HIV-1 Latency in Central Memory T Cells 6.72
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation [ChrRNA-seq] 6.63
Arginine citrullination at the C-terminal domain controls RNA Polymerase II transcription 6.62
T47D RNA-seq and ChrRNA-seq data 6.62
Sequencing-based analyses characterize a tumor suppressive role of mir-1271 repressed by DNA hypermethylation in gastric cancer 6.61
RNA-seq of cultured human kidney peritubular microvascular endothelial cells following exposure to cyclosporine A 6.61
Kidney organoid reproducibility across multiple human iPSC lines and diminished off target cells after transplantation revealed by single cell transcriptomics 6.6
Simultaneous quantification of antibody-RNA conjugates and the transcriptome from fixed cells by RAID 6.57
Deciphering the ‘m6A code’ via quantitative profiling of m6A at single-nucleotide resolution 6.55
Deciphering the ‘m6A code’ via quantitative profiling of m6A at single-nucleotide resolution [III] 6.55
Distinct regulation of alternative polyadenylation and gene expression by nuclear poly(A) polymerases 6.54
Mapping interactions for the TNIP2 hub protein 6.51
Characterization of transcriptomics landscape in HUVEC cells exposed to oxidative stress 6.51
Gene expression profiling by RNA-seq in hTert-HME1 cell line treated with control or BRCA2 siRNAs and grown with or without EGF (epithelial growth factor) 6.46
XPO1 inhibition antagonizes MCL via nuclear retention of IkB: Selinexor demonstrates antitumor activities in both ibr-sensitive and ibr-resistant tumor cells 6.44
MYC dependent mRNA translation shapes gene expression and cell biology 6.42
High-throughput sequencing of pluripotent cells 6.39
Messenger RNA profile analysis deciphers new Esrrb responsive genes in prostate cancer cells 6.36
pSILAC mass spectrometry reveals ZFP91 as novel IMiD dependent substrate of the CRL4CRBN ligase 6.35
RNA-sequencing of highly pure synovial tissue macrophages reveals two distinct osteoarthritis subgroups that indicate different disease mechanisms. 6.32
H19 regulates hepatic glucose production by epigenetic modification of Hnf4* 6.32
Identification of genes regulated by Long noncoding RNA H19 in hepatic cells 6.32
Selective roles of vertebrate PCF11 in premature and full-length transcript termination (chromatin-bound RNA-seq) 6.31
oxLDL exposed trained monocytes 6.3
Transcriptomes of oxLDL exposed trained monocytes 6.3
RIG-I and MDA5 fRIP during KSHV lytic reactivation 6.28
Tumor hypoxia causes DNA hypermethylation by reducing TET activity 6.27
Tumor hypoxia causes DNA hypermethylation by reducing TET activity (RNA-Seq) 6.27
A genome-wide long noncoding RNA CRISPRi screen identifies PRANCR as a novel regulator of epidermal homeostasis 6.27
Modeling the MYC-driven normal-to-tumour switch in breast cancer. 6.27
Comparative principles of DNA methylation reprogramming during human and mouse in vitro primordial germ cell specification [Mouse and Human RNA-seq and BS-seq] 6.24
Comparative principles of DNA methylation reprogramming during human and mouse in vitro primordial germ cell specification 6.24
PTP4A1 phosphatase is overexpressed in systemic sclerosis fibroblasts and promotes TGFb signaling 6.23
Transcriptome analysis of H9 hESC derived cerebral organoids 6.21
METTL3 and WTAP 6.21
Gene expression changes caused by KRAS in MCF-10A 6.15
RNA-seq profile of expanded human ST2-transduced Tregs cultured with IL-2 and TCR in the presence or absence of IL-33 6.13
DNMT and HDAC inhibitors globally induce cryptic TSSs encoded in long terminal repeats 6.04
Translocation of dense granule effectors across the parasitophorous vacuole membrane in Toxoplasma-infected cells requires the activity of ROP17, a rhoptry protein kinase 6.04
scRNASeq analysis of cycling cardiomyocytes 6.03
ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice 6.02
ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice [HCT116_RNA-seq] 6.02
Epigenetic Inactivation of Cysteine Dioxygenase Type 1 Contributes to ROS-dependent Progression of Colorectal Cancer 6.02
Transcriptome landscape of HeLa response upon triamcinolone acetonide 6.02
Long non-coding RNA SMILR regulates genes involved in cytokinesis in human vascular smooth muscle cell 6.0
Splicing and gene expression changes in human MDAM-MB231 breast cancer cells with TRA2B knockdown 5.92
IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner 5.91
IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner [Huh-7] 5.91
Cooperation of GRSF1 and the mitochondrial degradosome (hSuv3-PNPase complex) in degradation of mitochondrial RNA 5.91
NAPRT activation of macrophages 5.91
Identification and Initial Functional Characterization of SENCR, a Long Non-Coding RNA Enriched in Human Vascular Cells 5.89
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT, U0126, CYHX, ActD, EGF, FGF, or IGF and labelled with 4SU 5.84
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT and labelled with 4SU 5.84
miR-126 Orchestrates an Oncogenic Program in B-Cell Precursor Acute Lymphoblastic Leukemia 5.82
Mycobacterium bovis Bacillus Calmette-Guerin (BCG) reprograms melanoma microenvironment to promote antitumor T cell responses 5.8
Morphological and molecular characterization of human dermal lymphatic collectors 5.79
Toxoplasma gondii remodels the cis-regulatory landscape of infected human host cells 5.77
Toxoplasma gondii remodels the cis-regulatory landscape of infected human host cells [RNA-seq] 5.77
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation [RNA-Seq rescue_SS] 5.67
mRNA-Seq profiling of human developing kidney 5.62
Improved post thaw function and genetic changes for mesenchymal stromal cells cryopreserved using multicomponent osmolyte solutions 5.6
Treatment of SW480 colon cancer cell induced xenografts with AZD and DBZ 5.6
RNA-seq of HDAC2-disrupted 293FT cells by CRISPR-Cas9 5.55
Profiling of protrusion-enriched RNAs from human breast cancer cell line MDA-MB-231 5.55
Global transcriptional changes in the JJN3 myeloma cell line that occur as a result of treatment with 2 pyrrolobenzodiazepine (PBD) monomers 5.52
Human cells contain natural double-stranded RNAs with potential regulatory capacity 5.5
RNA sequencing to study transcriptomic changes in DLD-1 (colorectal adenocarcinoma) cells exposed to soft polyacrylamide matrices (~2 kPa and ~55 kPa) for short time scale of 90 minutes 5.49
Ex vivo expanded human 3D Nephrospheres engraft long term and repair chronic renal injury in mice 5.47
Genome-wide maps of m6A circRNAs identify widespread and cell-type-specific methylation patterns that are distinct from mRNAs 5.41
Global Transcriptome Analyses of Mammalian Terminal Erythroid Differentiation 5.4
Newly defined ABCB5+ dermal mesenchymal stem cells promote healing of chronic iron overload wounds via secretion of interleukin-1 receptor antagonist 5.38
RNA sequencing of isogenic BRCA2 haploinsufficient vs. wild-type T-ALL cells 5.36
RNA sequencing of primary human platelets and in vitro cell lines 5.36
Integrin signaling regulates YAP/TAZ to control skin homeostasis 5.33
RNA-seq analysis of differentiating human erythroblasts 5.29
A CLK3-HMGA2 alternative splicing axis impacts human hematopoietic stem cell molecular identity throughout development (HPC-5F RNAseq) 5.28
A Surveillance System of Active Enhancers by a RACK7-histone Demethylase Complex (RNA-Seq I) 5.27
β-catenin/Tcf7l2 dependent transcriptional regulation of GLUT1 gene expression by Zic family proteins in colon cancer 5.23
TimeLapse-seq: adding a temporal dimension to RNA sequencing through nucleoside recoding 5.15
MicroRNA targetome analysis during HCMV infection 5.12
Effects on gene expression of doxorubicin in human stem cells-derived cardiomyocytes 5.06
Transcriptome analysis of PC9 cells with gefitinib or/and hypoxia treatment and comparison with gefitinib resistant PC9 cells and ALDH positive PC9 cells 5.0
The bromodomain protein BRD4 regulates splicing during heat shock 4.99
CHD7 is Suppressed in the Perinecrotic/Ischemic Microenvironment and is a Novel Regulator of Angiogenesis 4.98
Bulk RNA-sequencing of cell types isolated by FACS from normal human prostates 4.98
Alagille_Nodder 4.94
RNA Seq of Alagille liver biopsies 4.94
Seletive inhibition of CDK9 in DLBCL cell lines 4.94
Transcriptome analysis of human immortilized astrocytes reprogrammed into dopaminergic neurons 4.92
Transcriptome analysis of CNS leukemia 4.81
RNA-seq analysis of primary patient samples to characterize the CNS leukemia 4.81
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 4.8
Transcriptomes of human monocytes after ex vivo exposure to uric acid 4.79
RNA sequencing of lesional and nonlesional skin from patients with atopic dermatitis 4.75
Reducing the structure bias of RNA-Seq reveals a large number of non-annotated non-coding RNA 4.71
MARCKS and lnc-MARCKS act as inflammation regulators 4.71
Time series single-cell transcriptomic analysis of AEC2 directed differentiation 4.71
IL-1β induces the rapid secretion of the antimicrobial protein IL-26 from Th17 cells 4.7
An atlas of TNF-α-responsive promoters and enhancers in the intestinal epithelial cell model Caco-2 4.68
RNA-Seq analysis and comparison of corneal epithelium in keratoconus and myopia patients 4.67
Nascent RNA Sequencing after NMYC activation in SH-EP MYCNER cells 4.66
Tyrosine-1 of RNAPII CTD controls global termination of gene transcription in mammals 4.63
Toxicogenomics of the flame retardant tris (2-butoxyethyl) phosphate in HepG2 cells using RNA-seq. 4.55
Transcriptome-wide analysis of the role of HTLV-1 Tax PBM in T-Cells from infected humanized-mice (hu-Mice) 4.51
A Primate lncRNA Mediates Notch Signaling During Neuronal Development by Sequestering miRNA [SHSY5Y cells] 4.48
RNA sequencing of CACO-2 cells incubated with bifidobacteria grown on human milk oligosaccharides. 4.48
Single-cell analysis of human kidney organoids 4.4
Antioxidant metabolism in activated CD8+ T cells regulates stem-like human memory T cell formation and anti-tumor immunity 4.37
Transcriptional profile of human STAT1-/- fibroblasts expressing IFI6 or empty control vector 4.35
Lyophilized human cells stored at room temperature preserve multiple RNA species at excellent quality for RNA sequencing 4.34
Differential Protein Occupancy Profiling of the mRNA Transcriptome 4.33
Measuring the effect of MYC on transcription during the DNA double-strand break response by RNA-seq of newly synthesized transcripts 4.29
Gene expression profiling of human CD19+ B cells and EBV transformed lymphoblastoid cell lines (LCLs) 4.21
Ribosome profiling upon inhibition of eIF4A 4.2
Uridylation-mediated RNA quality control pathway in mammalian cytoplasm [RNA-Seq] 4.2
TUT-DIS3L2 is a mammalian surveillance pathway for aberrant structured non-coding RNAs. 4.2
Rnase L reprograms translation by widespread mRNA turnover escaped by antiviral mRNAs 4.15
mRNA sequencing of the mouse and human Hep-Orgs, Chol-Orgs and primary hepatocytes 4.14
Non-transmissible measles virus vector with segmented RNA genome establishes different types of iPSCs from hematopoietic cells 4.13
Transcriptional changes in lymphoma cells induced by LSD1 depletion 4.12
Histone demethylase LSD1 is required for germinal center formation and BCL6 driven lymphomagenesis 4.12
Different Temporal Effects of Ebola Virus VP35 and VP24 Proteins on Global Gene Expression in Human Dendritic Cells 4.06
Targets of CDK12 on ZR-75-30 breast cancer cells (RNA-seq) 4.05
Distinct and shared functions of ALS-associated TDP-43, FUS, and TAF15 revealed by comprehensive multi-system integrative analyses [RNA-Seq_human] 4.04
Coronary Artery Disease Associated Transcription Factor TCF21 Regulates Smooth Muscle Precursor Cells that Contribute to the Fibrous Cap 4.04
Transcriptome profiling of 5 human adenocarcinoma cell lines 4.03
Consequences of Ribosomal Protein Haploinsufficiency in Human Hematopoiesis 3.99
3’READS+, a sensitive and accurate method for 3’ end sequencing of polyadenylated RNA 3.98
Genomic profiling of human spermatogonial stem cells [BulkRNA-Seq] 3.98
Exploring transcriptomic landscapes in red cell populations, in their extracellular vesicles and on single cell level 3.97
Transcriptional profile in human S. haematobium infection 3.97
Gene expression changes due to PARP knockdown in human cells 3.97
Image based identification and targeting of cancer stem cells in pancreatic adenocarcinoma (PDAC) 3.88
miR941 overexpression experiment 3.79
Assessing the effect of SUPT4H1 RNAi on the transcription of a repeat-containing reporter construct 3.75
Gene expression in control and DOCK8 CRISPR KHYG1 NK cells 3.72
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability (LNCaP RNA-seq) 3.7
O-glcnAc reprograms cellular energetics 3.69
Effect of PBK knockdown on C4-2 cell transcriptome 3.64
The transcriptomic differences between Th1, Tr1, and Tneg cells in controlled human malaria infection 3.61
Primary Human B-cell Temporal Response to CD40L Stimulation 3.6
Widespread Transcription beyond mRNA 3’ Ends Yields Abundant Regulatory RNAs 3.57
Targeting HuH7 cells with JumonjiC Lysine Demethylase Inhibitors (RNA-Seq) 3.52
Probing the Global Cellular Responses to Lipotoxicity Caused by Saturated Fatty Acids 3.52
SNHG15 is a bifunctional MYC-regulated noncoding locus encoding a lncRNA that promotes cell proliferation, invasion and drug resistance in colorectal cancer by interacting with AIF 3.5
Systematic analysis of gene expression profiles controlled by hnRNP Q and hnRNP R, two closely related human heterogeneous nuclear ribonucleoproteins. 3.49
The dynamic landscape of coding and non-coding RNAs in the innate immune response to microbial pathogens 3.47
Human Adult Sorted Live Cell Erythroblasts RNA-Seq. 3.46
RNA-Seq analysis of human Tr1, Tregs and IL10neg cells 3.46
Expanding the Nucleoside Recoding Toolkit: Revealing RNA Population Dynamics with 6-thioguanisine 3.39
Knock-down of Ror1 in MDA-MB-231 cell line decreases cell invasiveness 3.37
Coronary artery disease genes SMAD3 and TCF21 promote opposing interactive genetic programs that regulate smooth muscle cell differentiation and disease risk 3.35
Coronary artery disease genes SMAD3 and TCF21 promote opposing interactive genetic programs that regulate smooth muscle cell differentiation and disease risk [RNA-seq] 3.35
Multi-platform assessment of transcriptional profiling technologies utilizing a precise probe mapping methodology 3.35
Role of BET proteins in YAP/TAZ-dependent transcription [RNA-seq 2] 3.34
The Developmental Heterogeneity of Human Natural Killer Cells Defined by Single-cell Transcriptome 3.33
Chemotherapeutic drugs inhibiting Topoisomerase 1 activity inhibit TNF-induced inflammatory gene expression 3.32
The metabolome regulates the epigenetic landscape during naïve to primed human embryonic stem cell transition 3.23
Simultaneous and systematic analysis of cellular and viral gene expression during Enterovirus 71-induced host shutoff 3.2
An optimization system for isolating and sequencing of single human colon cancer cells 3.18
Simultaneous detection and relative quantification of coding and non-coding RNA using a single sequencing reaction 3.18
Circular RNA profiling reveals the different distribution/characteristic and possible transport mechanism among the subcellular fractions 3.17
The Genetic Landscape of Diamond-Blackfan Anemia 3.17
RNA editing in nascent RNA affects pre-mRNA splicing 3.16
CD86 regulates a pro-survival signal in myeloma cells 3.16
Single-cell analysis of adult human ovary using 10X genomics 3.1
TWIST1-induced microRNA-424 drives an intermediate epithelial-to-mesenchymal transition that opposes metastasis 3.06
Gene expression profile of HGC27 gastric cancer cell p53 KO and KD 3.04
Interactome (iCLIP) and Translatome ( Polysome profiling) of Musashi 2 (MSI2) targets in K562 3.04
CDK12 mediated transcriptional regulation in U2OS cells 3.03
The ARID1A tumor suppressor controls global transcription via pausing of RNA Polymerase II 3.0
Analysis of transcrptomes of Danon patient derived hiPSC-cardiomyocytes by RNA-deep Sequencing 2.96
Gene expression profiling of papillary thyroid cancer from central and invasive regions 2.95
MAIT cell RNA sequencing 2.92
Induction of human regulatory innate lymphoid cells from group 2 innate lymphoid cells by retinoic acid 2.89
Cell cycle dynamics of human pluripotent stem cells primed for differentiation 2.87
Dissecting the single-cell transcriptome network underlying gastric premalignant lesions and early gastric cancer [10x genomics] 2.84
Single-cell RNA-seq reveals differentiation of bona fide human pDCs and cDC1s in cultures of cord blood CD34+ progenitors, and a newly identified terminal differentiation step of cDC1s 2.79
MiR-CLIP capture of a miRNA targetome uncovers a lincRNA H19-miR-106a interaction [III] 2.77
Transcriptomic analysis of acute mitochondrial pyruvate carrier inhibition using UK5099 in ABL prostate cancer cells 2.75
Retinoic acid suppresses MYB in adenoid cystic carcinoma [RNA-seq] 2.74
Retinoic acid suppresses MYB in adenoid cystic carcinoma 2.74
NF-κB p65 dimerization and DNA-binding is important for inflammatory gene expression 2.72
High-throughput sequencing of PROMPT-enriched samples. 2.7
TALEN-based knockout of mir-141 and mir-200c in SK-BR-3 cells 2.67
Functional Inflammatory Profiles Distinguish Myelin-Reactive T Cells from Patients with Multiple Sclerosis 2.66
B-cell activating factor (BAFF) stimulation of Burkitt Lymphoma cell line 2.65
B-cell activating factor (BAFF) stimulation of Burkitt Lymphoma cell line [RNA-Seq] 2.65
Inhibition of H3K4 demethylation induces autophagy in cancer cell lines 2.65
Muscleblind-like 1 suppresses breast cancer metastatic colonization and stabilizes metastasis suppressor transcripts 2.6
MBNL1-dependent modulation of gene expression in MDA-MB-231 breast cancer cells 2.6
Expansion, in vivo-ex vivo cycling and genetic manipulation of primary human hepatocytes 2.57
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (pooled infection) 2.56
Epigenome Editing by a CRISPR/Cas9-Based Acetyltransferase Activates Genes from Promoters and Enhancers 2.54
Effect of ILF3 depletion in HeLa cells on RNA steady state levels 2.49
Identification of global XBP1s target gene expression in human prostate cancer cells 2.49
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [NALM6 RNA-Seq] 2.47
Inactivation of CFTR by CRISPR/Cas9 alters transcriptional regulation of inflammatory pathways and other networks 2.46
Next generation sequencing of the transcriptome in MCF-7 cells with/without SRA knockdown 2.46
Next Generation Sequencing Facilitates Quantitative Analysis of SW480 cells and HPSE-knockdown SW480 cells Transcriptomes 2.46
Epigenomes and transcriptomes of human monocytes before and after in vivo exposure to Bacillus Calmette-Guérin vaccine 2.45
Transcriptomic Analysis Of circRNAs/miRNAs/mRNAs upon Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection 2.45
An siRNA screen identifies CHD4 as a target for epigenetic therapy 2.44
Iron response of HepG2 cells 2.43
DDX54 regulates transcriptome dynamics during DNA damage response [RNA-seq2] 2.39
The transcription and translation landscapes during human cytomegalovirus infection reveal novel host-pathogen interactions 2.38
ADAR1-editing in HeLa, p150-KO and ADAR1-KO transcriptomes 2.38
ADAR1-editing of cellular and measles virus-derived duplex RNA 2.38
RING-finger protein 6 amplification activates JAK/STAT3 pathway by modifying SHP-1 ubiquitylation and associates with poor outcome in colorectal cancer 2.37
mRNA profiles of JMJD3 overexpression- and JMJD3 knockout- HL-60 cells 2.35
An evolutionary recent IFN-IL-6-CEBP axis is linked to monocyte expansion and tuberculosis severity in humans. 2.2
Complement protein C1q modulates macrophage molecular signaling and inflammatory responses during ingestion of atherogenic lipoproteins 2.19
Energy Metabolism during Anchorage-Independence 2.17
Epigenetic programming during monocyte to macrophage differentiation and trained innate immunity 2.15
A Reproducibility-Based Computational Framework Identifies An Inducible, Enhanced Antiviral Dendritic Cell State In HIV-1 Elite Controllers (scRNA-Seq) 2.14
miR-93 Targets in Human Endothelial Cells 2.13
GATA2 promotes hematopoietic development and represses cardiac differentiation of human mesoderm 2.13
CDK4/6 inhibitors target SMARCA4-determined cyclin D1 deficiency in hypercalcemic small cell carcinoma of the ovary (I) 2.12
Self-associated molecular patterns mediate cancer immune evasion by engagement of Siglec receptors 2.1
RNA-seq of ASXL2 shRNA KD in SKNO-1 cells 2.06
Profiling of lung tumor-infiltrating CD8 T cells according to their expression status of CD39 2.01
Human Cord Blood Sorted Live Cell Erythroblasts RNA-Seq 2.0
Structure and degradation of circular RNAs regulate PKR activation in innate immunity 1.94
RNA-Seq data of NCI-H82 cells expressing a Dox-On pRB (pTripZ RB1) grown in the presence or absence of DOX and then treated with vehicle or AZD2811. 1.89
Ribosome profiling of A549 cells depleted of RPLP1 and RPLP2 and infected with DENV. 1.88
The impact of oil spill to lung health – insights from an RNA-seq study of human airway epithelial cells 1.85
Hepatocyte maturation 1.83
Expression analysis of genes modulated after knock-down of lncRNA CHROME. 1.76
RAID allows multiplexed quantification of intracellular (phospho-)proteins and transcriptomes from fixed single cells 1.75
Epigenetic activation and memory at a TGFB2 enhancer in systemic sclerosis 1.72
Domain-focused CRISPR-screen identifies HRI as a fetal hemoglobin regulator in human erythroid cells 1.68
Wnt1 silences CC/CXC motif chemokine genes in dendritic cells and induces adaptive immune resistance in lung adenocarcinoma 1.67
Combinatorial Regulation Mediated by Biochemically Distinct Forms of SWI/SNF [RNA-Seq] 1.67
Genome-Wide Transcriptional Regulation Mediated By Biochemically Distinct Forms of SWI/SNF 1.67
C19ORF66 broadly escapes viral-induced endonuclease cleavage and restricts Kaposi’s Sarcoma Associated Herpesvirus (KSHV) 1.66
Effect of SF3B1 suppression in cancer cells with different SF3B1 copy-number levels 1.66
Pseudotime Ordering of Single Human Beta-Cells Reveals States of Insulin Production and Unfolded Protein Response 1.63
Disruption of the TFAP2A regulatory domain causes Branchio-Oculo-Facial Syndrome (BOFS) and illuminates pathomechanisms for other human neurocristopathies 1.62
Human Treg IFNg/IL-10 subpopulations 1.6
UPF1/SMG7-dependent MicroRNA-mediated Gene Regulation 1.59
A novel compound that blocks HIV-1 replication inhibits the splicing regulatory function of SRSF10 1.58
Epigenetic reprogramming of melanoma cells by vitamin C treatment 1.58
Hyperactive mTOR and MNK1 phosphorylation of eIF4E confer tamoxifen resistance and estrogen independence through selective mRNA translation reprogramming 1.56
B cells expressing the IgA receptor FcRL4 participate in the autoimmune response in patients with rheumatoid arthritis 1.55
Single cell transcriptomics analysis of induced pluripotent stem cell-derived cortical neurons reveals frequent dual layer identity 1.54
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 1.54
Investigation about Monocytes in metastatic breast cancer patients under chemotherapy +/- Avastin 1.54
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 1.54
Whole transcriptome profile of citrulline-specific B cells from patients with rheumatoid arthritis 1.53
Small-molecule-based Human Genome G4 Profiling Reveals Potential Gene Regulation Activity 1.44
single cell RNA-seq from GM12878 (ENCSR673UIY) 1.42
Small molecule-mediated reprogramming of human hepatocytes into bipotent progenitor cells 1.4
Functional Significance of U2AF1 S34F Mutation in Lung Adenocarcinomas 1.4
Tissue-resident memory T cells mediate immune homeostasis in the human pancreas through the PD-1/PD-L1 pathway 1.39
Identification of the RB loss-induced transcriptome and E2F1 cistrome in prostate cancer 1.31
Identification of the RB loss-induced transcriptome in prostate cancer [RNA] 1.31
KSRP specifies monocytic and granulocytic differentiation through regulating miR-129 biogenesis and RUNX1 expression 1.24
In vitro differentiation of human embryonic stem cells into ovarian follicle-like cells 1.23
Transcriptome-wide profiling of poly(A)-tail length, translation efficiency and mRNA stability using TED-seq, mRNA-seq, Ribo-seq and PRO-seq in ER stress conditions 1.23
Epigenetic profiling and RNA-sequencing of Juvenile Idiopathic Arthritits (JIA) patients 1.22
RNA-sequencing of cells derived from the site of inflammation of Juvenile Idiopathic Arthritis patients 1.22
Human MAIT cells exit peripheral tissues and re-circulate via lymph in steady state conditions 1.2
Function and hormonal regulation of GATA3 in human first trimester placentation 1.2
Treatment of prostate cancer cells with S-adenosylmethionine leads to genomewide alterations of transcription profiles 1.18
Does osteogenic potential of clonal human bone marrow mesenchymal stem/stromal cells correlate with their vascular supportive ability? 1.17
Kidney compartment specific eQTL studies highlight causal genes and pathways for renal disease development 1.16
Tracing Enhancer Networks using Epigenetic Traits (TENET) 1.16
RNA-seq analysis of BORIS/CTCFL knockdown in K562 cell line 1.11
RNA-seq and small RNA-seq analysis of BORIS/CTCFL knockdown in K562 cell line 1.11
Comparative Transcriptomic Analysis of Hematopoietic System Across Species by Microwell-Seq 1.11
Transcriptional profiling of PBMC from patients with aGvHD and patients without aGvHD after alloHSCT 1.09
CBFβ-MYH11 fusion blocks hematopoietic differentiation via repression of a GATA2 gene program 1.08
A monocyte gene expression signature in the early clinical course of Parkinson’s disease 1.07
Microenvironmental-derived Regulation of HIF-Signaling Drives Transcriptional Heterogeneity in Glioblastoma Multiforme 1.06
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia [inhibitor MRT199665] 1.02
Transcriptomic profiling of nasopharyngeal carcinoma (NPC) and normal control samples 1.02
SNHG5 siRNA knock down in HCT116 cells 0.99
Chromatin accessibility landscape upon induction of Msgn1, Pax3 and Myf5 in mesodermal cells and identification of conserved Pax3 binding sites and target genes during skeletal myogenesis 0.98
Transcriptome profiling of A2M treated A549 Cell Line Samples 0.98
Engineered Nanointerfaces for Microfluidic Isolation and Molecular Profiling of Tumor-specific Extracellular Vesicles 0.96
A Reproducibility-Based Computational Framework Identifies An Inducible, Enhanced Antiviral Dendritic Cell State In HIV-1 Elite Controllers (TLR perturbation Bulk RNA-Seq) 0.96
High-throughput sequencing of the human hepatic progenitor cell niche in PSC and HCV. 0.95
RNA-seq transcriptional profiling in primary human erythroid progenitor cells upon shRNA-mediated knockdown of PRC2 core subunits 0.95
ChIP-seq and RNA-seq analysis of PRC2 core subunits in primary human erythroid progenitor cells 0.95
Impact on erythroid progenitor type on erythroid differntiation 0.93
Transriptional profiling upon heat shock and recovery in cells deficient for FBXW7 and their wild type counterpart. 0.9
FBXW7 modulates stress response by post-translational modification of HSF1 0.9
Transcriptomic profile of intestinal epithelial cells obtained from ileal endoscopic biopsies from newly-diagnosed, pediatric Crohn's disease patients and healthy controls. 0.88
Effect of BB608 on Gene Expression in HNSCC Cell Line 0.88
RNA expression profiles from HUVECs overexpressing adenovirally delivered HIF1a and HIF2a proteins 0.86
Expression of MERTK based on Multiple Sclerosis (MS) risk haplotype 0.83
RNA deep sequencing to compare genome-wide differences between PRMT5/knockdown and control AML cells 0.83
The novel lncRNA lnc-NR2F1 is pro-neurogenic and mutated in human neurodevelopmental disorders [lnc-Nr2f1 overexpression] 0.73
The novel lncRNA lnc-NR2F1 is pro-neurogenic and mutated in human neurodevelopmental disorders 0.73
Characterization of transcriptomics landscape in HUVEC cells exposed to oxidative stress (Total RNA) 0.71
High-resolution comparative analysis of great ape genomes 0.71
A Suv39H1-low chromatin state drives migratory cell populations in cervical cancer 0.7
A Suv39H1-low chromatin state drives migratory cell populations in cervical cancer [RNA-Seq] 0.7
RNA-seq data 0.66
RNA-seq and flow-cytometry of conventional, scalp, and palmoplantar psoriasis reveal shared and distinct molecular pathways 0.6
Highly-motile versus unsorted MDA-MB-231 breast cancer cells 0.56
EGR1-controlled transcriptome of T HESCs 0.54
High-throughput single cell transcriptome analysis and CRISPR screen identify key β cell-specific disease genes 0.53
Identification of a unique gene expression signature in mercury and 2,3,7,8-tetrachlorodibenzo-p-dioxin co-exposed cells 0.53
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (separate infection) 0.52
MicroRNA-125a-5p overexpression in human macrophages 0.45
siRNA-mediated knockdown 0.45
Dermal endothelial cells of type 2 diabetic patients 0.44
The mRNA export receptor NXF1 coordinates transcriptional dynamics, alternative polyadenylation and mRNA export 0.43
HMGA2 Promotes Long-Term Engraftment and Myelo-Erythroid Differentiation of Human Hematopoietic Stem and Progenitor Cells 0.43
A toxicogenomics approach to screen chlorinated flame retardants tris(2-chloroethyl) phosphate and tris(2-chloroisopropyl) phosphate for potential health effects 0.41
hsa-miR-503, hsa-miR-103, and hsa-miR-494 genome wide target profiles [RNA-Seq and RIP-Seq] 0.39
Genome-wide hsa-miR-503, hsa-miR-103, and hsa-miR-494 target profiles 0.39
KRASG12C inhibition produces a driver-limited state revealing collateral dependencies 0.38
Global transcriptome analysis of WT versus HEB-/- hESCs 0.32
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [SLAM-Seq] 0.28
Gene expression analysis of human adenomas. 0.28
Transcription elongation regulates genome 3D structure 0.28
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. [RNA-Seq] 0.27
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. 0.27
Human Treg IL-12 stimulation 0.27
Genome-wide DNA hypomethylation and RNA:DNA hybrid accumulation in Aicardi-Goutières syndrome 0.24
Distinct and shared functions of ALS-associated TDP-43, FUS, and TAF15 revealed by comprehensive multi-system integrative analyses [RNA-Seq_Stability] 0.23
Transcriptome analysis reveals determinant stages controlling human embryonic stem cell commitment to neuronal cells 0.18
Myc activation coordinates gene transcription and protein translation responses 0.16
Next generation sequencing of advanced non-castrate prostate cancer treated with docetaxel chemotherapy 0.15
Low-dose decitabine priming endows CAR T cells with enhanced and persistent anti-tumor potential by epigenetic reprogramming 0.13
RNA-seq of HUVEC ± shRNA knockdown of SENCR 0.13
IMP3 regulated gene expression in breast cancer cells 0.11
Determining mRNA half-lives on a transcriptome-wide scale 0.1
Differential LINE-1 retrotransposition in induced pluripotent stem cells between humans and great apes 0.1
Hsa-miR-371a-5p and hsa-miR-518a-3p regulated genes in choriocarcinoma cells 0.1
Preclinical model of obesity and ER-positive breast cancer 0.09
Transcriptional changes during naturally-acquired ZIKA Virus infection render dendritic cells highly conducive to viral replication 0.06
single cell RNA-seq from Purkinje cell (ENCSR888LYA) 0.04
Enhancer activation during EGF response 0.04
Inhibition of TAZ contributes radiation-induced senescence and growth arrest in glioma cells 0.01


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation